Pages that link to "Item:Q5754831"
From MaRDI portal
The following pages link to Phase 2 and 3 Combination Designs to Accelerate Drug Development (Q5754831):
Displayed 7 items.
- A prospective combination of phase II and phase III in drug development (Q478229) (← links)
- A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054) (← links)
- A review of phase 2-3 clinical trial designs (Q1029784) (← links)
- Likelihood inference for a two-stage design with treatment selection (Q3076084) (← links)
- Interim Design Modifications in Time-to-Event Studies (Q4916467) (← links)
- Confidence intervals for confirmatory adaptive two‐stage designs with treatment selection (Q4921948) (← links)
- Two‐Stage Designs for Dose‐Finding Trials with a Biologic Endpoint Using Stepwise Tests (Q5450485) (← links)